Ibn Alhaytham HospitalAMM:IBNH 33 EBITDA Margin % is 11.49% as of Mar. 2026, which is 24% below its 10-year median of 15.17. GuruFocus rates AMM:IBNH with a GF Score™ of 33/100 and a GF Value™ of JOD0.83 (Fairly Valued). The stock has 9 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Ibn Alhaytham Hospital ranks better than 72.16% on this metric.
Ibn Alhaytham Hospital (AMM:IBNH) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Ibn Alhaytham Hospital EBITDA Margin % Related Terms
Ibn Alhaytham Hospital EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Ibn Alhaytham Hospital's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AMM:IBNH vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Ibn Alhaytham Hospital's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ibn Alhaytham Hospital EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ibn Alhaytham Hospital's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Ibn Alhaytham Hospital's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ibn Alhaytham Hospital (AMM:IBNH) has a EBITDA Margin % of 11.49% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ibn Alhaytham Hospital and its competitors. This is 24% below median its historical median of 15.17. According to the industry distribution chart, Ibn Alhaytham Hospital ranks #186 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 27.8%.
Is Ibn Alhaytham Hospital's EBITDA Margin % too high?
Ibn Alhaytham Hospital's current EBITDA Margin % of 11.49% is 24% below median its 10-year median of 15.17. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Ibn Alhaytham Hospital's value of 11.49% is 12.5% above this industry median. Based on the distribution chart, Ibn Alhaytham Hospital ranks #186 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ibn Alhaytham Hospital has a GF Score™ of 33/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ibn Alhaytham Hospital's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ibn Alhaytham Hospital ranks #186 out of 668 companies for EBITDA Margin %. This puts Ibn Alhaytham Hospital in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Ibn Alhaytham Hospital's value of 11.49% is 12.5% above this benchmark. While the company's 10-year median is 15.17 vs. the industry median of 10.21, Ibn Alhaytham Hospital has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ibn Alhaytham Hospital's current EBITDA Margin % of 11.49% is 12.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ibn Alhaytham Hospital and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ibn Alhaytham Hospital's current EBITDA Margin % is 11.49%, which is 24% below median its own 10-year median of 15.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ibn Alhaytham Hospital stock overvalued right now?
Based on GuruFocus' analysis, Ibn Alhaytham Hospital (AMM:IBNH) is currently considered Fairly Valued. The stock's GF Value™ is JOD0.83, compared to a current price of JOD0.86 — trading 3.6% above its estimated fair value. The current EBITDA Margin % is 11.49%, which is 24% below median its 10-year median of 15.17 and 12.5% above the Healthcare Providers & Services industry median of 10.21. Ibn Alhaytham Hospital's overall GF Score™ is 33/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Ibn Alhaytham Hospital (AMM:IBNH), the current EBITDA Margin % is 11.49% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ibn Alhaytham Hospital (AMM:IBNH) Overvalued in 2026?
Based on GuruFocus' analysis, Ibn Alhaytham Hospital stock appears to be overvalued.
The current stock price of JOD0.86 is trading 3.6% above its estimated GF Value™ of JOD0.83.
GuruFocus considers Ibn Alhaytham Hospital to be Fairly Valued.
Key valuation signals for AMM:IBNH:
EBITDA Margin %: 11.49% (24% below median its 10-year median of 15.17)
GF Value™: JOD0.83 vs. price of JOD0.86 (3.6% above fair value)
Industry Position: 12.5% above the Healthcare Providers & Services median (#186 of 668)
No single metric tells the full story. See the AMM:IBNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ibn Alhaytham Hospital operates as a hospital in Jordan. The Company's main objectives is to found and establish a hospital for general casses And especially ophthalmology, Otorhinolaryngology, Medicine and Neurosurgery and to Import a necessary medical equipment and supplies. The company operates in segments, which comprise of Medical & investments and others.
33GF Score
Get the complete analysis for AMM:IBNH
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:IBNH has been successfully added to your 
